Aufbau Holdings Ltd. is the parent corporation of Aufbau Medical Innovations Ltd., a biotechnology startup company conducting research and development for novel diagnostic and therapeutic platform technologies for the detection, monitoring, and treatment of ophthalmic disorders and life-threatening systemic cancers.

Aufbau Holdings is the parent company to promising biotechnology companies in the ophthalmic therapeutic space.

Aufbau Holdings is a global research company headquartered in Dublin, Ireland. Our research company in the United States conducts research and development for technology geared to the US market.